Chen S - Search Results

1

Cancer Cell enters reversible quiescence through Intracellular Acidification to resist Paclitaxel Cytotoxicity.

Jia M, Zheng D, Wang X, Zhang Y, Chen S, Cai X, Mo L, Hu Z, Li H, Zhou Z, Li J. Jia M, et al. Among authors: chen s. Int J Med Sci. 2020 Jun 29;17(11):1652-1664. doi: 10.7150/ijms.46034. eCollection 2020. Int J Med Sci. 2020. PMID: 32669967 Free PMC article.

2

Norcantharidin inhibits DNA replication and induces mitotic catastrophe by degrading initiation protein Cdc6.

Chen S, Wan P, Ding W, Li F, He C, Chen P, Li H, Hu Z, Tan W, Li J. Chen S, et al. Among authors: chen p. Int J Mol Med. 2013 Jul;32(1):43-50. doi: 10.3892/ijmm.2013.1359. Epub 2013 Apr 23. Int J Mol Med. 2013. PMID: 23612688

3

Norcantharidin inhibits the DDR of bladder cancer stem-like cells through cdc6 degradation.

Shi X, Chen S, Zhang Y, Xie W, Hu Z, Li H, Li J, Zhou Z, Tan W. Shi X, et al. Among authors: chen s. Onco Targets Ther. 2019 Jun 7;12:4403-4413. doi: 10.2147/OTT.S209907. eCollection 2019. Onco Targets Ther. 2019. PMID: 31239709 Free PMC article.

4

Norcantharidin counteracts acquired everolimus resistance in renal cell carcinoma by dual inhibition of mammalian target of rapamycin complex 1 and complex 2 pathways in Vitro.

Chen X, Cai X, Zheng D, Huang X, Chen Y, Deng T, Mo L, Li H, Li J, Chen S. Chen X, et al. Among authors: chen s, chen y. Anticancer Drugs. 2022 Jan 1;33(1):e94-e102. doi: 10.1097/CAD.0000000000001147. Anticancer Drugs. 2022. PMID: 34261913

5

Norcantharidin inhibits pre-replicative complexes assembly of HepG2 cells.

Chen S, Qu X, Wan P, Li QW, Wang Z, Guo F, Bai L, Hu Z, Tan W, Li J. Chen S, et al. Am J Chin Med. 2013;41(3):665-82. doi: 10.1142/S0192415X13500468. Am J Chin Med. 2013. PMID: 23711148

6

Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells.

Chen S, Chen X, Xie G, He Y, Yan D, Zheng D, Li S, Fu X, Li Y, Pang X, Hu Z, Li H, Tan W, Li J. Chen S, et al. Among authors: chen x. Oncotarget. 2016 Jun 28;7(26):40362-40376. doi: 10.18632/oncotarget.9616. Oncotarget. 2016. PMID: 27246979 Free PMC article.

7

Sequential administration of GM-CSF and IL-2 surface-modified MB49 cells vaccines against the metastatic bladder cancer.

Shi X, Zhang X, Li J, Guo F, Hu Z, Jing Y, Bai L, Chen S, Wan P, Wang F, Gao J, Tan W. Shi X, et al. Among authors: chen s. Urol Oncol. 2013 Aug;31(6):883-93. doi: 10.1016/j.urolonc.2011.08.001. Epub 2011 Sep 15. Urol Oncol. 2013. PMID: 21924648

8

Comparison of the therapeutic effects of adipose‑derived and bone marrow mesenchymal stem cells on erectile dysfunction in diabetic rats.

Chen S, Zhu J, Wang M, Huang Y, Qiu Z, Li J, Chen X, Chen H, Xu M, Liu J, She M, Li H, Yang X, Wang Y, Cai X. Chen S, et al. Among authors: chen x, chen h. Int J Mol Med. 2019 Sep;44(3):1006-1014. doi: 10.3892/ijmm.2019.4254. Epub 2019 Jun 24. Int J Mol Med. 2019. PMID: 31257465 Free PMC article.

9

AAV-Mediated angiotensin 1-7 overexpression inhibits tumor growth of lung cancer in vitro and in vivo.

Chen X, Chen S, Pei N, Mao Y, Wang S, Yan R, Bai N, Li A, Zhang Y, Du H, Chen B, Sumners C, Li J, Li H. Chen X, et al. Among authors: chen b, chen s. Oncotarget. 2017 Jan 3;8(1):354-363. doi: 10.18632/oncotarget.13396. Oncotarget. 2017. PMID: 27861149 Free PMC article.

10

[Construction of a recombinant lentiviral vector of p38 MAPK and establishment of a human prostatic carcinoma cell line stably expressing p38 MAPK].

Jing YM, Luo J, Zhang YL, Chen SS, Wan P, Yan RH, Wang HC, Chen BH, Tan WL, Li HW. Jing YM, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2012 Mar;32(3):317-21. Nan Fang Yi Ke Da Xue Xue Bao. 2012. PMID: 22445974 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88,243 results

Search Page

Filters